<DOC>
	<DOCNO>NCT02851784</DOCNO>
	<brief_summary>The study observe safety , survival effect peripheral T-lymphocyte subset combination therapy percutaneous microwave ablation ( MWA ) adoptive immunotherapy hepatocellular carcinoma ( HCC ) .</brief_summary>
	<brief_title>Combination Therapy Microwave Ablation Cellular Immunotherapy Hepatocellular Carcinoma</brief_title>
	<detailed_description>HCC ( D ≤5 cm , few three tumor ) patient treat radical MWA 4-6 course immunotherapy CIK every year . The immunotherapy start 2 week , 4 week , 6 week , 10 week , 14 week , 18 week every 12 week MWA . Peripheral blood mononuclear cell differentiate phenotypically confirm DCs effector cell . DC-CIK CTL inject abdominal cavity . CIK infuse intravenously . The safety , survival effect peripheral T-lymphocyte subset combination therapy group record compare MWA group .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>1. single HCC 5 cm small ; 2. three few multiple HCC maximum dimension 3 cm less ; 3. absence portal vein thrombosis extrahepatic metastasis ; 4 . ChildPugh classification A B ; 5. tumor accessible via percutaneous approach . white blood cell count &gt; 2 x 109/L , platelet count &gt; 40 x 109/L , serum creatinine &lt; 110 μmol/L , aspartate aminotransferase &lt; 3 time upper limit , serum bilirubin &lt; 2.5 time upper limit , prothrombin time &lt; 19 second . 1. pregnant breastfeeding ; psychiatric problem , addiction , disorder prevent informed consent ; 2. active uncontrolled infection ; concurrent systemic corticosteroid treatment ; 3. systemic autoimmune disease ; 4. clinically significant ischemic heart disease cardiac failure ; 5. chemotherapy radiotherapy within precede 6 month</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>hepatocellular carcinoma</keyword>
	<keyword>ablation</keyword>
	<keyword>immunotherapy</keyword>
	<keyword>cytokine induce kill cell</keyword>
</DOC>